Exact Mass: 430.293

Exact Mass Matches: 430.293

Found 19 metabolites which its exact mass value is equals to given mass value 430.293, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

MG(PGF1alpha/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid

C23H42O7 (430.293)


MG(PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGF1alpha/0:0)

1,3-Dihydroxypropan-2-yl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid

C23H42O7 (430.293)


MG(0:0/PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(2:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C23H42O7 (430.293)


DG(2:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C23H42O7 (430.293)


DG(18:1(12Z)-2OH(9,10)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C23H42O7 (430.293)


DG(2:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C23H42O7 (430.293)


DG(18:1(12Z)-2OH(9,10)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

88-deoxylankolide

88-deoxylankolide

C23H42O7 (430.293)


   

[1R-(1a,2b,3a,5a)]-5-Hydroxy-2-[(1-methoxy-1-methylethoxy)methyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentaneheptanoic acidmethylester

[1R-(1a,2b,3a,5a)]-5-Hydroxy-2-[(1-methoxy-1-methylethoxy)methyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentaneheptanoic acidmethylester

C23H42O7 (430.293)


   

MG(PGF1alpha/0:0/0:0)

MG(PGF1alpha/0:0/0:0)

C23H42O7 (430.293)


   

MG(0:0/PGF1alpha/0:0)

MG(0:0/PGF1alpha/0:0)

C23H42O7 (430.293)


   

DG(2:0/18:1(12Z)-2OH(9,10)/0:0)

DG(2:0/18:1(12Z)-2OH(9,10)/0:0)

C23H42O7 (430.293)


   

DG(18:1(12Z)-2OH(9,10)/2:0/0:0)

DG(18:1(12Z)-2OH(9,10)/2:0/0:0)

C23H42O7 (430.293)


   

DG(2:0/0:0/18:1(12Z)-2OH(9,10))

DG(2:0/0:0/18:1(12Z)-2OH(9,10))

C23H42O7 (430.293)


   

DG(18:1(12Z)-2OH(9,10)/0:0/2:0)

DG(18:1(12Z)-2OH(9,10)/0:0/2:0)

C23H42O7 (430.293)


   

17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid

17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid

C23H42O7 (430.293)


   

(16R)-16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid

(16R)-16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid

C23H42O7 (430.293)


   

Hexadecanedioic acid, bis(trimethylsilyl) ester

Hexadecanedioic acid, bis(trimethylsilyl) ester

C22H46O4Si2 (430.2934)


   

(3r,4r,5s,6s,7s,9r,11s,12r,13r,14s)-4,6,12-trihydroxy-14-(3-hydroxybutan-2-yl)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

(3r,4r,5s,6s,7s,9r,11s,12r,13r,14s)-4,6,12-trihydroxy-14-(3-hydroxybutan-2-yl)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

C23H42O7 (430.293)


   

4,6,12-trihydroxy-14-(3-hydroxybutan-2-yl)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

4,6,12-trihydroxy-14-(3-hydroxybutan-2-yl)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

C23H42O7 (430.293)